🇨🇦 efavirenz, emtricitabine, and tenofovir in Canada

efavirenz, emtricitabine, and tenofovir (efavirenz, emtricitabine, and tenofovir) regulatory status in Canada.

Marketing authorisation

efavirenz, emtricitabine, and tenofovir in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is efavirenz, emtricitabine, and tenofovir approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for efavirenz, emtricitabine, and tenofovir in Canada?

University of North Carolina, Chapel Hill is the originator. The local marketing authorisation holder may differ — check the official source linked above.